Ad
related to: rch guidelines whooping cough treatment antibiotics
Search results
Results From The WOW.Com Content Network
Cases of whooping cough are surging across the country. Doctors share symptoms, how to prevent pertussis, vaccination information, and treatments amid outbreak. What Doctors Want You to Know About ...
Whooping cough (/ ˈ h uː p ɪ ŋ / or / ˈ w uː p ɪ ŋ /), also known as pertussis or the 100-day cough, is a highly contagious, vaccine-preventable bacterial disease. [1] [10] Initial symptoms are usually similar to those of the common cold with a runny nose, fever, and mild cough, but these are followed by two or three months of severe coughing fits. [1]
In 2023, there were 51 cases of pertussis, commonly called whooping cough, in Wisconsin. As of Sept. 13, there have been 625 cases this year, according to the Department of Health Services.
However, babies who contract whooping cough often don't cough at all. Instead, they turn blue or struggle to breathe, and about one-third of those under 1 year old will need hospital care to fight ...
Some cough medicines may be no more effective than placebos for acute coughs in adults, including coughs related to upper respiratory tract infections. [7] The American College of Chest Physicians emphasizes that cough medicines are not designed to treat whooping cough, a cough that is caused by bacteria and can last for months. [8]
Bordetella pertussis is a Gram-negative, aerobic, pathogenic, encapsulated coccobacillus bacterium of the genus Bordetella, and the causative agent of pertussis or whooping cough. Its virulence factors include pertussis toxin , adenylate cyclase toxin , filamentous haemagglutinin , pertactin , fimbria , and tracheal cytotoxin .
The current resurgence has brought over 15,000 whooping cough cases nationally, which is five times the number of cases we had at this time last year, according to the CDC.
Tetracyclines are generally used in the treatment of infections of the urinary tract, respiratory tract, and the intestines and are also used in the treatment of chlamydia, especially in patients allergic to β-lactams and macrolides; however, their use for these indications is less popular than it once was due to widespread development of resistance in the causative organisms.